The company has significantly boosted the development of an innovative therapy for ATTR-CM, leveraging the investigational drug. Early patient data indicates promising benefits for individuals affected from the severe https://attruby516465.atualblog.com/48833529/bridgebio-improves-attr-cm-management-through-the-therapy